Skip to main content
OpenTrials
Completed

NCT Number: NCT06012630

Carpal Tunnel Syndrome Evaluation With Ultrasound in Rheumatoid Arthritis Patients

In rheumatoid arthritis (RA) patients, the diagnosis of Carpal tunnel syndrome (CTS) was made based on clinical findings and physical examinations. Then, the cross-sectional areas of the participants' median nerves from different levels were measured. Meidolateral and anteroposterior diameter were measured at the level of the carpal tunnel inlet. Flattening ratio was calculated. wrist to forearm ratio and wrist to forearm difference were calculated. The obtained data were compared between RA with CTS, RA without CTS and healthy control.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Median Nerve Entrapment Arthritis Arthritis, Rheumatoid Autoimmune Diseases Carpal Tunnel Syndrome Connective Tissue Diseases Cumulative Trauma Disorders Immune System Diseases Joint Diseases Median Neuropathy Mononeuropathies Musculoskeletal Diseases Nerve Compression Syndromes Nervous System Diseases Neuromuscular Diseases Peripheral Nervous System Diseases Rheumatic Diseases Skin and Connective Tissue Diseases Sprains and Strains Wounds and Injuries

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Istanbul Training and Resarch Hospital

Istanbul, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • RA patients identified according to the 2010 American College of Rheumatology/Europan Leage Against Rheumatism classification criteria
  • healthy controls (HC) with no history of rheumatic diseases and CTS.
  • Individuals aged 18-65 years.

Exclusion criteria

  • thoese with hypothyroidism,
  • gout,
  • diabetes mellitus,
  • history of CTS surgery,
  • upper extremity plexopathy,
  • polinöropathy,
  • uncontrollable fibromyalgia,
  • steroid injection for CTS
  • For the HC group, those with phalen or tinnel detected in at least one wrist and those with bifid median nerve detected during US evaluation were not included in the study.

Treatment and study plan

Ultarsound

Diagnostic Test

Median nerve evaluation of participants with ultrasound

Primary outcomes

  1. Comparison of US findings among participants

    Time frame: 6 months

    Comparison of US findings among participants

Secondary outcomes

  1. Relationship between US findings and disease activity in the patient group

    Time frame: 6 months

    The correlation between the US findings of the participants in the patient group and the CDA, which evaluates disease activity, was examined.

Sponsors and collaborators

Lead sponsor

Burak Tayyip Dede

Other Gov

Registry information

Official study title

Ultrasound Evaluation of the Median Nerve in Patients With Rheumatoid Arthritis and Its Relationship With Disease Activity

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Aug 25, 2023
Registry last updated
Aug 25, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.